" class="no-js "lang="en-US"> Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices
Sunday, March 26, 2023

Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices

In the video, Patrick Jeukenne, VP of Strategy Business Development & Marketing at Aptar Pharma, explains the importance of drug delivery devices in ensuring patients receive the correct dose of medication, and how innovation in the field is constantly improving the patient experience. Jeukenne explains the challenges involved in designing drug delivery devices that are user-friendly, easy to use, and safe for patients. He emphasizes the need for collaboration between various stakeholders, including patients, healthcare providers, and device manufacturers, to achieve these goals.

Jeukenne also discusses the potential of connected drug delivery devices, which can collect and transmit data about patients’ medication use to healthcare providers. This technology can improve medication adherence and patient outcomes, but also raises concerns about patient privacy and data security. Jeukenne emphasizes the importance of balancing the benefits of connected devices with these concerns.

Overall, Jeukenne’s discussion highlights the critical role that drug delivery devices play in modern healthcare, and the ongoing efforts to improve their design, functionality, and safety.

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more